- Anew Medical (WENA) stock is rising on Tuesday on development plans.
- The company plans to advance its patented Klotho gene therapy program.
Anew Medical (NASDAQ:WENA) stock is soaring higher on Tuesday after the biopharmaceutical company announced advancement plans for its patented Klotho gene therapy program.
According to Anew Medical, it intends to advance this treatment for neurodegenerative disorders. It’s doing so alongside initial data showing Klotho levels may affect ALS, Alzheimer’s and Parkinson’s Disease.
Anew Medical intends to start clinical trials of its Klotho gene therapy program. The company will also work on diagnostic tools to allow for the measuring of Klotho levels. Finally, it plans to explore the ability to promote longevity in healthy individuals using its program.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.